1. Hydrogen Sulfide Ameliorates Lipopolysaccharide-Induced Memory Impairment in Mice by Reducing Apoptosis, Oxidative, and Inflammatory Effects
   Viplav Kshirsagar et al, 2021, Neurotoxicity Research CrossRef
2. Alzheimer’s disease and neuroinflammation: will new drugs in clinical trials pave the way to a multi-target therapy?
   Daniela Melchiorri et al, 2023, Frontiers in Pharmacology CrossRef
3. Dl-3-n-Butylphthalide Exerts Dopaminergic Neuroprotection Through Inhibition of Neuroinflammation
   Yajing Chen et al, 2019, Frontiers in Aging Neuroscience CrossRef
4. DL-3-n-butylphthalide alleviates motor disturbance by suppressing ferroptosis in a rat model of Parkinson’s disease
   Li-Hua Shen et al, 2023, Neural Regeneration Research CrossRef
5. Eupatorium Lindleyanum DC. Extract Protects against MPTP-induced Mouse of Parkinson’s Disease by Targeting Neuroinflammation
   Yichi Zhang et al, 2024, International Journal of Drug Discovery and Pharmacology CrossRef
6. From Seeds ofApium graveolensLinn. to a Cerebral Ischemia Medicine: The Long Journey of 3-n-Butylphthalide
   José Marco-Contelles et al, 2020, Journal of Medicinal Chemistry CrossRef
7. Neuroprotective mechanisms of 3‑n‑butylphthalide in neurodegenerative diseases (Review)
   Rixin Luo et al, 2019, Biomedical Reports CrossRef
8. 3-N-butylphthalide attenuates neuroinflammation in rotenone-induced Parkinson’s disease models via the cGAS-STING pathway
   Yuqian Liu et al, 2024, International Journal of Immunopathology and Pharmacology CrossRef
9. Effect of Dl-3-n-Butylphthalide on olfaction in rotenone-induced Parkinson’s rats
   Jiawei Wang et al, 2024, Frontiers in Neurology CrossRef
10. Co-administration of Nanowired DL-3-n-Butylphthalide (DL-NBP) Together with Mesenchymal Stem Cells, Monoclonal Antibodies to Alpha Synuclein and TDP-43 (TAR DNA-Binding Protein 43) Enhance Superior Neuroprotection in Parkinson’s Disease Following Concussive Head Injury
    Lianyuan Feng et al, 2023, Progress in Nanomedicine in Neurologic Diseases CrossRef